Skip to main content Skip to footer

AGILE Press release: Search for effective COVID-19 treatments

Novel clinical trial platform launched to test new treatments in Liverpool

The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit announced this week that they have launched their innovative COVID-19 drug testing platform, AGILE. The AGILE initiative is a collaboration between the University of Liverpool, Liverpool School of Tropical Medicine, Southampton Clinical Trials Unit, University of Southampton and Lancaster University, as well as other partners. AGILE has been developed by Infectious Diseases clinicians, clinical and pre-clinical pharmacologists, clinical trials specialists and statisticians. The result is a clinical trials platform that can test new drugs for COVID-19 and identify faster than ever before those compounds which could be game changers in the battle against COVID-19………

Other posts

Case study from @Medidata

Take a look at this case study from @Medidata who are supporting @SouthamptonCTU with the AGILE clinical trial platform #COVID19 #clinicaltrials
Read More

Covid-19 Drug interactions

The Liverpool Drug Interactions website team developed a freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents…
Read More